Journal
BIOMEDICINES
Volume 10, Issue 12, Pages -Publisher
MDPI
DOI: 10.3390/biomedicines10123126
Keywords
lysophospholipids; neurodegenerative diseases; amyloid; alpha-synuclein
Categories
Funding
- Japan Society for the Promotion of Science KAKENHI [22H03516]
Ask authors/readers for more resources
Neurodegenerative diseases are characterized by protein misfolding and aggregation. Inhibiting this aggregation may be a potential therapeutic strategy, and dietary bioactive phospholipids have been suggested to possess this ability. However, further research is needed to understand the mechanisms involved.
Neurodegenerative diseases (NDs) commonly present misfolded and aggregated proteins. Considerable research has been performed to unearth the molecular processes underpinning this pathological aggregation and develop therapeutic strategies targeting NDs. Fibrillary deposits of alpha-synuclein (alpha-Syn), a highly conserved and thermostable protein, are a critical feature in the development of NDs such as Alzheimer's disease (AD), Lewy body disease (LBD), Parkinson's disease (PD), and multiple system atrophy (MSA). Inhibition of alpha-Syn aggregation can thus serve as a potential approach for therapeutic intervention. Recently, the degradation of target proteins by small molecules has emerged as a new therapeutic modality, gaining the hotspot in pharmaceutical research. Additionally, interest is growing in the use of food-derived bioactive compounds as intervention agents against NDs via functional foods and dietary supplements. According to reports, dietary bioactive phospholipids may have cognition-enhancing and neuroprotective effects, owing to their abilities to influence cognition and mental health in vivo and in vitro. However, the mechanisms by which lipids may prevent the pathological aggregation of alpha-Syn warrant further clarification. Here, we review evidence for the potential mechanisms underlying this effect, with a particular focus on how porcine liver decomposition product (PLDP)-derived lysophospholipids (LPLs) may inhibit alpha-Syn aggregation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available